BarriGel
Commercial- Indications
- Post-surgical adhesion prevention
Company intelligence / Profile preview
Han Biomedical Inc. develops and markets medical materials for tissue reconstruction and repair using natural biomaterials. Its main products include BarriGel, an anti-post-surgical adhesion gel; Hancare, a collagen scaffold for wound healing; as well as other healthcare products such as patient lubricants, gauze, and hyaluronic acid solutions. The company is active in the domestic Taiwanese market with commercialized products but does not appear to have clinical-stage drug development programs.[1][4][5]
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Han Biomedical Inc..